SCHEMBL6723710

SCHEMBL6723710

CS(=O)(=O)c1ccc(-c2c(-c3ccccc3)noc2C(F)F)cc1F

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 13/20 0.45
ALDH1A1 P00352 1/20 0.41
MAPK14 Q16539 4/20 0.39
CSNK1D P48730 3/20 0.39
MT-CO2 P00403 3/20 0.39
PTGS1 P23219 2/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
LMNA P02545 1/20 0.39
CA3 P07451 1/20 0.39
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
CYP3A4 P08684 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CHRM1 P11229 1/20 0.39
ADRA2B P18089 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6721948 0.92 PTGS2 (0.48) PTGS2MAPK14CSNK1DPTGS1MAPK9
SCHEMBL6722731 0.91 PTGS2 (0.42) PTGS2ALDH1A1MAPK14CSNK1DPTGS1
SCHEMBL6729612 0.91 PTGS2 (0.39) PTGS2MAPK14CSNK1DPTGS1MAPK9
SCHEMBL6726701 0.90 PTGS2 (0.38) PTGS2ALDH1A1MAPK14CSNK1DPTGS1
SCHEMBL6722959 0.90 PTGS2 (0.43) PTGS2ALDH1A1MAPK14CSNK1DMAPK9
SCHEMBL6725529 0.89 PTGS2 (0.38) PTGS2MAPK14CSNK1DPTGS1MAPK9
SCHEMBL6730308 0.89 PTGS2 (0.37) PTGS2ALDH1A1MAPK14LMNANPC1
SCHEMBL6721919 0.88 PTGS2 (0.45) PTGS2ALDH1A1MAPK14CSNK1DMT-CO2
SCHEMBL6723756 0.88 PTGS2 (0.39) PTGS2MAPK14CSNK1DPTGS1MAPK9
SCHEMBL6719286 0.88 PTGS2 (0.34) PTGS2ALDH1A1MAPK14CSNK1DMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2004-05-13 US disclosed
EP-1296971-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION Pharmacia Corporation (US) 2003-04-02 EP disclosed
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation PHARMACIA CORPORATION 2002-12-05 US disclosed
WO-2001081332-A2 2-FLUOROBENZENESULFONYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION PHARMACIA CORPORATION (US) 2001-11-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183362-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, FPR1, PTGES2 PTGS2 5/4885ALDH1A1 263/4885MAPK14 2499/4885
US-20040092552-A1 2-Fluorobenzenesulfonyl compounds for the treatment of inflammation FPR2, PTGES2, FPR1 PTGS2 5/4885ALDH1A1 298/4885MAPK14 2354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.